Plain language summary looking at how long side effects last after treatment with axitinib is stopped in people with advanced renal cell carcinoma
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - August 1, 2023 Category: Cancer & Oncology Authors: Brian I Rini Michael B Atkins Toni K Choueiri Rosemary E Teresi Brad Rosbrook Maghull Thakur Thomas E Hutson Source Type: research
TROPION-Breast02: Datopotamab deruxtecan for locally recurrent inoperable or metastatic triple-negative breast cancer
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - August 1, 2023 Category: Cancer & Oncology Authors: Rebecca A Dent David W Cescon Thomas Bachelot Kyung Hae Jung Zhi-Ming Shao Shigehira Saji Tiffany A Traina Petra Vukovic Darlington Mapiye Micah J Maxwell Peter Schmid Javier Cort és Source Type: research
The first Middle East and North Africa expert consensus recommendations for management of advanced gastric cancer
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - August 1, 2023 Category: Cancer & Oncology Authors: Hampig Raphael Kourie Mervat Mahrous Nabih Naim Joseph Zouein Zineb Benbrahim Kakil Rasul Mohsen Mokhtar Ahmad Al Shehri Mahmoud Shakeeb Sami Khatib Humaid Al-Shamsi Ali Shamseddine Elisabeth Smyth Source Type: research
TGF- β: the apex predator of immune checkpoints
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - July 28, 2023 Category: Cancer & Oncology Authors: Bryan Oronsky Pedro Cabrales Babak Alizadeh Scott Caroen Meaghan Stirn Jeannie Williams Tony R Reid Source Type: research
Pediatric oncohematological exercise program in hospital: clinical trial study protocol
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - July 27, 2023 Category: Cancer & Oncology Authors: Cintia Freire Carniel Beatriz M Rosin Bruna Cunha de Souza Rodrigo Daminello Raimundo Source Type: research
Durvalumab real-world treatment patterns and outcomes in patients with stage III non-small-cell lung cancer treated in a US community setting
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - July 27, 2023 Category: Cancer & Oncology Authors: David Waterhouse Candice Yong Andrew Frankart Lance Brannman Tiernan Mulrooney Nicholas Robert Kathleen M Aguilar Juliet Ndukum Ion Cotarla Source Type: research
Cilta-cel, a BCMA-targeting CAR-T therapy for heavily pretreated patients with relapsed/refractory multiple myeloma
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - July 27, 2023 Category: Cancer & Oncology Authors: Thomas G Martin Deepu Madduri Lida Pacaud Saad Z Usmani Source Type: research
Addition of PI3K/AKT/mTOR inhibitors to fulvestrant for advanced HR+/HER2- breast cancer: a systematic review and meta-analysis
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - July 27, 2023 Category: Cancer & Oncology Authors: Tianqi Zhang Danni Xie Xinhui Ye Yinuo Wang Xue Sun Qingchun Zhao Tianshu Ren Source Type: research
Response heterogeneity as a new biomarker of treatment response in patients with neuroendocrine tumors
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - July 27, 2023 Category: Cancer & Oncology Authors: Clarisse Dromain Marianne Pavel Maxime Ronot Niklaus Schaefer Dalvinder Mandair Delphine Gueguen Catherine Cheng Olivier Dehaene Kathryn Schutte David Cahan é Simon J égou F élix Balazard Source Type: research
The use of deep learning models to predict progression-free survival in patients with neuroendocrine tumors
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - July 27, 2023 Category: Cancer & Oncology Authors: Marianne Pavel Clarisse Dromain Maxime Ronot Niklaus Schaefer Dalvinder Mandair Delphine Gueguen David Elvira Simon J égou F élix Balazard Olivier Dehaene Kathryn Schutte Source Type: research
Plain language summary of the MonumenTAL-1 study of talquetamab in people with relapsed or refractory multiple myeloma
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - July 26, 2023 Category: Cancer & Oncology Authors: Ajai Chari Elham Askari Jo Caers Luciano J. Costa Brandi W. Hilder Amrita Krishnan Mar ía-Victoria Mateos Monique C. Minnema Albert Oriol Kodandaram Pillarisetti Niels W.C.J. van de Donk Paula Rodr íguez-Otero Source Type: research
Deep learning-based multiomics integration model for predicting axillary lymph node metastasis in breast cancer
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - July 25, 2023 Category: Cancer & Oncology Authors: Xue Li Lifeng Yang Xiong Jiao Source Type: research
Time to next treatment in patients with chronic lymphocytic leukemia initiating first-line ibrutinib or acalabrutinib
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - July 21, 2023 Category: Cancer & Oncology Authors: Ryan Jacobs Xiaoxiao Lu Bruno Emond Laura Morrison Frederic Kinkead Patrick Lefebvre Marie-H élène Lafeuille Wasiulla Khan Linda H Wu Zaina P Qureshi Moshe Yair Levy Source Type: research
The burden of ovarian cancer in the USA from 2007 to 2018: evidence from the Medical Expenditure Panel Survey
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - July 21, 2023 Category: Cancer & Oncology Authors: Elizabeth A Szamreta Wei-Jhih Wang Ruchit Shah Shelby Corman Matthew Monberg Source Type: research
The effects of Managing Cancer and Living Meaningfully (CALM) on psychological distress in esophageal cancer patients
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - July 20, 2023 Category: Cancer & Oncology Authors: Yinlian Cai Jie Zhao Wen Li Sheng Yu Lingxue Tang Senbang Yao Huaidong Cheng Source Type: research
